This application note describes the extraction of Δ9-THC (tetrahydrocannabinol), 11-hydroxy- Δ9-THC and 11-nor-9-carboxy-THC from whole blood matrix, prior to GC/MS analysis. An extremely simple sample pre-treatment and extraction method is employed to extract the parent THC and main metabolites from complex whole blood matrix, delivering high, reproducible analyte recoveries. The optimized SLE+ protocol demonstrated analyte recoveries ranging from 72-83%. RSD’s were below 10% for all analytes.
New Method for Determination of Voriconazole in Plasma
Biotage Receives the SwedenBIO Award 2019
New Method for Determination of 1, 4-Dioxane in Drinking Water
New Application Note for Determination of Mycophenolic Acid
Two Alternative Approaches to the Extraction of a Suite of Regulated Veterinary Growth Promoters